Advertisement Easton Pharma to launch FSAD drug in Mexico - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Easton Pharma to launch FSAD drug in Mexico

Easton Pharmaceuticals intends to launch Viorra cosmeceutical retail products in Mexico, as a part of its plan to introduce the drug across North America, South America and Mexico.

Viorra is a non-invasive topical treatment to assist women who are suffering from a range of female sexual arousal disorders (FSAD) that cause a lack of vaginal lubricity and sensation.

Easton claims Viorra restores a woman’s vaginal lubricity and assists in improved sensation.

Easton is also developing a pipeline of transdermal products using its proprietary technology in Viorra for men, plus a variety of topical applications, including treatments for women and men seeking to diminish scars, adhesions, cellulite, varicose veins and stretch marks.